 | Up a level |
Al Hamed, Rama; Labopin, Myriam; Wu, Depei; Gedde-Dahl, Tobias; Aljurf, Mahmoud; Forcade, Edouard; Salmenniemi, Urpu; Passweg, Jakob; Maertens, Johan; Pabst, Thomas; Versluis, Jurjen; Itäla-Remes, Maija; Huang, Xiao-Jun; Van Gorkom, Gwendolyn; Schroeder, Thomas; Sanz, Jaime; Blaise, Didier; Reményi, Péter; Schanz, Urs; Esteve, Jordi; ... (2024). Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT. (In Press). Bone marrow transplantation Springer Nature 10.1038/s41409-024-02373-5
Sanz, Jaime; Labopin, Myriam; Pabst, Thomas; Versluis, Jurjen; Van Gorkom, Gwendolyn; Meijer, Ellen; Gedde-Dahl, Tobias; Montoro, Juan; Arcese, William; Pérez-Simón, Jose Antonio; Schaap, Nicolaas; Maertens, Johan; Vrhovac, Radovan; Lanza, Francesco; Gorin, Norbert Claude; Mohty, Mohamad; Ciceri, Fabio (2023). Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation, 58(11), pp. 1197-1202. Nature Publishing Group 10.1038/s41409-023-02075-4
